195 results
DEFA14A
ADVM
Adverum Biotechnologies Inc
11 Jun 24
Additional proxy soliciting materials
4:19pm
matters.
In connection with his service on the Board, Dr. Kiss will participate in the Company’s standard compensation program for non-employee directors
8-K
ADVM
Adverum Biotechnologies Inc
11 Jun 24
Departure of Directors or Certain Officers
4:16pm
in the Company’s standard compensation program for non-employee directors, which is described in the Company’s proxy supplement for the Company’s 2024 Annual
DEFA14A
ADVM
Adverum Biotechnologies Inc
28 May 24
Additional proxy soliciting materials
2:00pm
.
Amendment and Restatement of Non-Employee Director Compensation Policy
The Company maintains a non-employee director compensation policy. In May … 2024, the compensation committee of the Company’s board of directors approved the amendment and restatement of the Company’s non-employee director
8-K
EX-99.1
ADVM
Adverum Biotechnologies Inc
9 May 24
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
4:10pm
Committee of Adverum’s Board of Directors granted a new non-executive employee a stock option to purchase 21,000 shares of Adverum’s common stock
8-K
EX-3.2
xpq64i 9bfwig
20 Mar 24
Material Modifications to Rights of Security Holders
4:13pm
8-K
EX-99.2
iuq7wbhw vv02kv
6 Feb 24
In the Court of Chancery of the State of Delaware
4:47pm
8-K
EX-99.1
h0gbjbnf yu
6 Feb 24
In the Court of Chancery of the State of Delaware
4:47pm
8-K
EX-10.1
6c17oaiqr 0qaim1
5 Feb 24
Entry into a Material Definitive Agreement
5:03pm
8-K/A
il8nv t24fc8dwyin8mt
4 Dec 23
Departure of Directors or Certain Officers
4:09pm
8-K
4p96z4ho2vnpq7c7l
6 Nov 23
Departure of Directors or Certain Officers
4:10pm